Emergent BioSolutions Inc. 8-K

What Happened

• Emergent BioSolutions Inc. filed a Form 8-K on January 14, 2026, disclosing that President and CEO Joseph C. Papa will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
• The company furnished its investor presentation slides as Exhibit 99.1 to the 8-K; those slides are incorporated by reference into the filing.

Key Details

• Presenter: Joseph C. Papa, President & Chief Executive Officer.
• Event: 44th Annual J.P. Morgan Healthcare Conference, presentation date January 14, 2026.
• Exhibit: Investor Presentation dated January 14, 2026 filed as Exhibit 99.1.
• Filing item: Regulation FD Disclosure reported under Item 7.01 of the Form 8-K.

Why It Matters

• This is a routine, Regulation FD-compliant disclosure giving investors and analysts direct access to management’s presentation and slides.
• The furnished slides may contain updates on strategy, programs, or outlook that investors can review to assess the company’s recent messaging and priorities.